CDSCO panel to Sun Pharma to manufacture Progesterone SR Tablet
The drug major Sun Pharma has got green signal from the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) to manufacture and market the Progesterone Sustained Release (SR) Tablets (200/300/400mg).
This came after the firm presented their proposal along with the bioavailability (BE) study report of Progesterone Sustained Release tablet 400mg before the committee.
Sustained Release (SR) Tablets are designed to release a drug in the body slowly over an extended period of time. It allows delivery of a specific drug at a programmed rate that leads to drug delivery for a prolonged period of time.
For more details, check out the link given below:
Sun Pharma Gets CDSCO Panel Nod To Manufacture, Market Progesterone SR Tablet
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd